Clover Biopharmaceuticals, Ltd. (HKG:2197)
1.910
-0.085 (-4.26%)
Sep 11, 2026, 4:08 PM HKT
Clover Biopharmaceuticals Employees
Clover Biopharmaceuticals had 257 employees as of June 30, 2026. The number of employees did not change since the number was reported on December 31, 2025.
Employees
257
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
2.48B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 257 | 0 | - |
| Dec 31, 2025 | 257 | -43 | -14.33% |
| Dec 31, 2024 | 300 | -87 | -22.48% |
| Dec 31, 2023 | 387 | -377 | -49.35% |
| Dec 31, 2022 | 764 | -50 | -6.14% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Viva Biotech Holdings | 2,213 |
| Frontage Holdings | 1,523 |
| AIM Vaccine | 1,466 |
| BioDlink International Company | 594 |
| Jiangsu Recbio Technology | 466 |
| Beijing Luzhu Biotechnology | 213 |
| Antengene Corporation | 122 |
| Laekna | 83 |
Clover Biopharmaceuticals News
- 5 months ago - Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV Re-Vaccination In Older Adults - Nasdaq